AcquisitionOther
Novartis AG acquired Regulus Therapeutics Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Novartis AG -> Regulus Therapeutics Inc. · $7.00 per share plus CVR
Acquire therapeutics company to expand pipeline in key disease areas.
Open source record (SEC) ↗